View Section: Company Analysis
Corbus Pharmaceuticals Rating
CR
CRBP stock is not rated by Eyestock analysis.
The model does not consider the rating of companies that have no revenue
Discover High-rated Companies
View Section: Valuation
CR
Last reporting period 30 Sep, 2023
Updated 12 Nov, 2024
Last price
—
Market cap $B
0.221
Exchange
XNAS - Nasdaq
CR
CRBP stock is not rated by Eyestock analysis.
The model does not consider the rating of companies that have no revenue